Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer.
Peng H, James CA, Cullinan DR, Hogg GD, Mudd JL, Zuo C, Takchi R, Caldwell KE, Liu J, DeNardo DG, Fields RC, Gillanders WE, Goedegebuure SP, Hawkins WG.
Peng H, et al. Among authors: takchi r.
Clin Cancer Res. 2021 Dec 15;27(24):6761-6771. doi: 10.1158/1078-0432.CCR-21-0998. Epub 2021 Sep 30.
Clin Cancer Res. 2021.
PMID: 34593529
Free PMC article.